Biostax Corp.
BTAX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.78% | 39.80% | -63.63% | 33.19% | 54.13% |
| Total Depreciation and Amortization | -66.01% | 2.99% | 205.97% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.13% | -63.97% | 646.90% | -53.74% | -85.15% |
| Change in Net Operating Assets | 21.44% | 108.10% | 142.19% | 20.81% | 465.95% |
| Cash from Operations | 181.49% | 122.66% | 75.16% | 29.88% | 84.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -127.37% | -117.90% | -81.57% | -61.06% | -59.41% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -127.41% | -117.92% | -81.60% | -61.09% | -59.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 100.00% | -- | -- | -- |
| Net Change in Cash | 97.51% | 93.15% | 91.82% | 64.86% | -216.03% |